XRD patterns of 17-4PH-xTiC coatings. by Dian Yu Luo (22656111)

“…Compared to the commercial blade, the wear of the laser-cladded blade was decreased by 67%. This study successfully applied wear-resistant laser cladding coatings on the surface of harvester blades with small substrate thickness, significantly extending their service life.…”

Data Sheet 1_Prepandemic levels of cytokines and immunoglobulins and risk of SARS-CoV-2 infection and COVID-19 in the general population of Barcelona.docx by Miquel Porta (199379)

“…</p>Results<p>Higher concentrations in 2016–17 of IL-8 and TNF-α significantly decreased the risk of SARS-CoV-2 seropositivity in 2020–21, whereas higher concentrations of MIP-1α were a risk factor for seropositivity. …”

Image 1_Elevated thiamine level is associated with activating interaction between HIF-1α and SLC19A3 in experimental myopic guinea pigs.jpeg by Zhongyu Ma (12275357)

“…</p>Results<p>Compared with the normal control (NC) group, the LIM group guinea pigs showed a significant increase in axial length and decrease in refractive error, as well as a thinning of choroidal thickness and loosening of tissue structure. …”

Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…Almost all pediatric patients (56; 81.2%) were treated under A-level indications, as for 217 (65.6%) adults. In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…Almost all pediatric patients (56; 81.2%) were treated under A-level indications, as for 217 (65.6%) adults. In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…Almost all pediatric patients (56; 81.2%) were treated under A-level indications, as for 217 (65.6%) adults. In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…Almost all pediatric patients (56; 81.2%) were treated under A-level indications, as for 217 (65.6%) adults. In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…Almost all pediatric patients (56; 81.2%) were treated under A-level indications, as for 217 (65.6%) adults. In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…Almost all pediatric patients (56; 81.2%) were treated under A-level indications, as for 217 (65.6%) adults. In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…Almost all pediatric patients (56; 81.2%) were treated under A-level indications, as for 217 (65.6%) adults. In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table1_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.DOCX by J. Riera-Arnau (20431328)

“…Almost all pediatric patients (56; 81.2%) were treated under A-level indications, as for 217 (65.6%) adults. In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

The circadian LPN promote sleep through AstC pathway. by Xin Yuan (174619)

“…(H, I) Thermogenetic inhibition of LPNs with Shibire^TS (<i>LPN-spGal4>Shib</i>^<i>TS</i>; red line) leads to a significant decrease in sleep relative to baseline. …”

AC-LPN circuit control high temperature induced increase of evening sleep. by Xin Yuan (174619)

“…Data (G) were quantified with unpaired <i>t</i> test. ns = not significant, *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001, ****<i>P</i> < 0.0001. …”

Effect of Biomass-to-catalyst ratio on pyrolysis kinetics. by Ning Zuo (17295415)

Subjects:

Experimental Workflow for the Conversion of Wastewater Algal Biomass to Biogas via Cobalt-based Catalytic Pyrolysis and Methanogenic Archaea Co-Anaerobic Fermentation. by Ning Zuo (17295415)

Subjects:

(a) Carbon emissions (%) as a function of temperature for the integrated and control systems. (b) Output mass of biochar (g) at various temperatures for the integrated and control... by Ning Zuo (17295415)

Subjects:

Thermogravimetric Analysis (TGA) of biomass and biochar. by Ning Zuo (17295415)

Subjects:

(a) X-ray diffraction (XRD) pattern of the cobalt nitrate catalyst, showing the crystallinity and phase structure of the Co/Al₂O₃ catalyst. (b) Fourier transform infrared (FTIR) sp... by Ning Zuo (17295415)

Subjects:

<b> </b> Energy efficiency and gas volume comparison. by Ning Zuo (17295415)

Subjects:

(a) Calorific value of biogas (MJ) as a function of temperature for the integrated and control systems. (b) Total gas volume (mL) produced at varying temperatures for the integrate... by Ning Zuo (17295415)

Subjects: